eprex 6000 injekció fecskendőben (hsa mentes)
janssen-cilag kft. - eritropoetin -
eprex 7000 injekció fecskendőben (hsa mentes)
janssen-cilag kft. - eritropoetin -
eprex 8000 injekció fecskendőben (hsa mentes)
janssen-cilag kft. - eritropoetin -
eprex 9000 injekció fecskendőben (hsa mentes)
janssen-cilag kft. - eritropoetin -
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianémiás készítmények - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - egyéb vérszegénység elleni szerek - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
emren 10 mg tabletta
janssen-cilag kft. - a ramipril -
evrenzo
astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianémiás készítmények - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).